Gsk Plc Stock Performance
| GLAXF Stock | USD 23.00 0.80 3.36% |
On a scale of 0 to 100, GSK Plc holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and GSK Plc are completely uncorrelated. Please check GSK Plc's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether GSK Plc's current trending patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in GSK plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, GSK Plc reported solid returns over the last few months and may actually be approaching a breakup point. ...more
GSK |
GSK Plc Relative Risk vs. Return Landscape
If you would invest 2,067 in GSK plc on September 30, 2025 and sell it today you would earn a total of 233.00 from holding GSK plc or generate 11.27% return on investment over 90 days. GSK plc is currently producing 0.2141% returns and takes up 3.0075% volatility of returns over 90 trading days. Put another way, 26% of traded pink sheets are less volatile than GSK, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
GSK Plc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GSK Plc's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as GSK plc, and traders can use it to determine the average amount a GSK Plc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0712
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GLAXF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average GSK Plc is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GSK Plc by adding it to a well-diversified portfolio.
GSK Plc Fundamentals Growth
GSK Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of GSK Plc, and GSK Plc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GSK Pink Sheet performance.
| Return On Equity | 0.31 | |||
| Return On Asset | 0.0659 | |||
| Profit Margin | 0.51 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 90.86 B | |||
| Shares Outstanding | 4.09 B | |||
| Price To Earning | 11.44 X | |||
| Price To Book | 6.49 X | |||
| Price To Sales | 1.91 X | |||
| Revenue | 29.32 B | |||
| EBITDA | 8.8 B | |||
| Cash And Equivalents | 6.53 B | |||
| Cash Per Share | 1.62 X | |||
| Total Debt | 19.76 B | |||
| Debt To Equity | 0.98 % | |||
| Book Value Per Share | 2.63 X | |||
| Cash Flow From Operations | 7.4 B | |||
| Earnings Per Share | 1.32 X | |||
| Total Asset | 60.15 B | |||
| Retained Earnings | (6.55 B) | |||
| Current Asset | 17.61 B | |||
| Current Liabilities | 18.14 B | |||
About GSK Plc Performance
By analyzing GSK Plc's fundamental ratios, stakeholders can gain valuable insights into GSK Plc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if GSK Plc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GSK Plc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.Things to note about GSK plc performance evaluation
Checking the ongoing alerts about GSK Plc for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for GSK plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GSK plc had very high historical volatility over the last 90 days |
- Analyzing GSK Plc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GSK Plc's stock is overvalued or undervalued compared to its peers.
- Examining GSK Plc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GSK Plc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of GSK Plc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GSK Plc's pink sheet. These opinions can provide insight into GSK Plc's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for GSK Pink Sheet analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |